BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 04, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Belinostat: Phase II ongoing

Spectrum said an independent DMC recommended the continuation of the open-label pivotal Phase II BELIEF trial based on a futility analysis and review of safety data from the first 45 patients. The trial is evaluating daily 1,000 mg/m...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >